At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Somnetics Transcend Auto +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcend Auto vs Commercially Available Device Clinical Evaluation for Treatment of Obstructive Sleep Apnea (OSA)
In Brief
A clinical study evaluating Somnetics Transcend Auto and Respironics REMstar Auto with C-Flex for Obstructive Sleep Apnea. Completed, enrolled 41 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine whether the Transcend Auto is as effective in treating obstructive sleep apnea as another device that is already on the market.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 2013
Enrollment StartFeb 2013
Primary CompletionJun 2013
TodayJul 2026
First PostedFeb 26, 2013
Enrollment StartFeb 27, 2013
Primary CompletionJun 10, 2013
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 13.3 years ago
Interventions
Somnetics Transcend Autodevice
Respironics REMstar Auto with C-Flexdevice